| Gene symbol | DLL3 | Synonyms | SCDO1 | Type of gene | protein-coding | |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | Entrez:10683 MIM:602768 HGNC:HGNC:2909 Ensembl:ENSG00000090932 AllianceGenome:HGNC:2909 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | delta like canonical Notch ligand 3 | |||||
| GTO ID | GTC3865 |
| Trial ID | NCT06384482 |
| Disease | Small Cell Lung Cancer | Lung Large Cell Neuroendocrine Carcinoma |
| Altered gene | DLL3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | SNC115 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | To Evaluate the Safety and Pharmacokinetic of SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Crcinoma: an Open-label, Single-arm, Dose Escalation Exploratory Study |
| Year | 2024 |
| Country | China |
| Company sponsor | Shanghai Simnova Biotechnology Co.,Ltd. |
| Other ID(s) | SNC115-DLL3 CART-101 |
| Cohort 1 | |||||||||
|
|||||||||